Dewpoint and Chemify partner on molecules targeting condensates in oncology and neurodegeneration
Sep. 13, 2023
Dewpoint Therapeutics Inc. and Chemify Ltd. have partnered to develop a suite of digitally discovered and automatically synthesized novel molecules on Chemify’s programmable chemistry platform against condensate targets of interest in Dewpoint’s oncology and neurodegeneration pipeline.